In-vitro studies have demonstrated that targeting LDHA can reduce the proliferation, migration, and invasion of pancreatic cancer, and in-vivo studies have shown that tumor growth is decreased [32, 36]. The gene discussed is LDHA; the disease is familial pancreatic carcinoma.